Equifax Q2 Earnings & Revenues Surpass Estimates, Increase Y/Y

Equifax (EFX) reported a strong second quarter 2025, with adjusted EPS of $2, up 9.9% year-over-year and beating estimates by 4.2%, on total revenues of $1.5 billion, up 7.4% and exceeding consensus. This outperformance was primarily driven by robust growth in its Workforce Solutions and USIS segments, which both surpassed expectations. Consequently, EFX raised its Q3 and full-year 2025 revenue and EPS guidance, though the updated 2025 EPS mid-point of $7.5 remains slightly below the Zacks Consensus Estimate of $7.62, while the company's shares have significantly outperformed the industry year-to-date.

Analysis

Equifax (EFX) reported a strong second-quarter 2025, exceeding consensus estimates on both revenue and earnings. Total revenues grew 7.4% year-over-year to $1.5 billion, while adjusted EPS rose 9.9% to $2.00, beating forecasts by 1.5% and 4.2% respectively. The performance was primarily driven by robust growth in its two core domestic segments: Workforce Solutions, which saw revenues climb 8% to $662.1 million, and USIS, which grew 9% to $521.5 million. This strength was complemented by expanding profitability, as the company's adjusted EBITDA margin increased by 50 basis points to 32.5%, with margin improvement registered across all segments. However, the International division's revenue of $353.4 million missed estimates despite growing 4% on a reported basis. While management raised its Q3 and full-year 2025 guidance, a key point of caution is that the new midpoint for full-year adjusted EPS ($7.50) remains below the existing consensus estimate of $7.62, potentially tempering investor enthusiasm despite the positive quarterly results and the stock's significant outperformance against its industry year-to-date.

Key Decisions for Investors

• Given the strong execution in core U.S. segments and upwardly revised guidance, the results support a constructive view, though investors should note the stock has already outperformed its industry peers significantly this year.
• The primary risk factor to monitor is the full-year 2025 EPS guidance, which, despite being raised, still falls short of consensus expectations, a discrepancy that could cap further share price appreciation until it is resolved.
• Investors should scrutinize the performance of the International segment in upcoming quarters, as its revenue miss presents a relative weakness, and any signs of acceleration could serve as a future growth catalyst.